TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T82266	Voltage-gated L-type calcium channel	D04ZAH	Piperacillin	Approved	43672	C23H27N5O7S	517.6	CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O	IC50 = 1226000 nM	Non binder
T82266	Voltage-gated L-type calcium channel	D0CL9S	Telbivudine	Approved	159269	C10H14N2O5	242.23	CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O	IC50 = 713900 nM	Non binder
T82266	Voltage-gated L-type calcium channel	D0F0YZ	Pentobarbital	Approved	4737	C11H18N2O3	226.27	CCCC(C)C1(C(=O)NC(=O)NC1=O)CC	IC50 = 299000 nM	Non binder
T82266	Voltage-gated L-type calcium channel	D0H3WI	Ribavirin	Approved	37542	C8H12N4O5	244.2	C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N	IC50 = 622500 nM	Non binder
T82266	Voltage-gated L-type calcium channel	D0I1FQ	Raltegravir	Approved	54671008	C20H21FN6O5	444.4	.	IC50 = 246700 nM	Non binder
T82266	Voltage-gated L-type calcium channel	D0M4YC	Disopyramide	Approved	3114	C21H29N3O	339.5	CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C	IC50 = 1036700 nM	Non binder
T82266	Voltage-gated L-type calcium channel	D0N3VR	Voriconazole	Approved	71616	C16H14F3N5O	349.31	C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O	IC50 = 414200 nM	Non binder
T82266	Voltage-gated L-type calcium channel	D0U5SI	Procainamide	Approved	4913	C13H21N3O	235.33	CCN(CC)CCNC(=O)C1=CC=C(C=C1)N	IC50 = 389500 nM	Non binder